Literature DB >> 3154634

Effects of acetyl strophanthidin on duration of atrial fibrillation in the neurally-intact and blockaded dog.

A M Mokraoui1, H S Friedman, L A Melniker, T N Nguyen.   

Abstract

Although the inotropic and dromotropic effects of cardiac glycosides in atrial fibrillation (AF) are well recognized, their action on AF itself is not clear. Accordingly, to determine whether cardiac glycosides prolong AF, the duration of electrically induced AF, atrioventricular conduction, and left ventricular function were assessed for 30 minutes before and for 30 minutes following intravenous administration of acetyl strophanthidin (AS), 20 micrograms/kg, in neurally intact, beta-blocked, and beta-blocked and vagotomized dogs. In the intact dog, AS, 20 micrograms/kg, increased peak dp/dt by 132 +/- 35 mmHg.sec-1, p less than 0.05, and slowed ventricular response by 16 +/- 7 min-1, p less than 0.05, but had a variable effect on AF duration. While the increased left ventricular peak dp/dt persisted for 15 minutes after AS, an increased duration of AF was evident only at 20 minutes, when the effects of AS on left ventricular (LV) inotropy were no longer apparent. Moreover, the subset of dogs that did not demonstrate prolongation of average duration of AF after AS had a greater increment of peak dp/dt than those that showed prolongation, 237 +/- 52 versus 53 +/- 31 mmHg.sec-1, p less than 0.05. An additional 20 micrograms/kg, which produced ventricular extrasystoles, prolonged AF duration when compared to both control and 30-minute measurements. Acetyl strophanthidin, 20 micrograms/kg, had a variable effect on duration of AF with beta-blockade but prolonged duration by 114 +/- 34%, p less than 0.05, with both vagotomy and beta-blockade.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3154634     DOI: 10.1007/bf00051197

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  13 in total

1.  Digitalis: A neuroexcitatory drug.

Authors:  R A Gillis
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

2.  ACTION POTENTIALS OF GUINEA PIG ATRIA UNDER CONDITIONS WHICH ALTER CONTRACTION.

Authors:  W SLEATOR; R F FURCHGOTT; T DE GUBAREFF; V KRESPI
Journal:  Am J Physiol       Date:  1964-02

3.  Electrophysiological effects of strophanthin in the heart.

Authors:  D G KASSEBAUM
Journal:  J Pharmacol Exp Ther       Date:  1963-06       Impact factor: 4.030

4.  Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge.

Authors:  G K MOE; J A ABILDSKOV
Journal:  Am Heart J       Date:  1959-07       Impact factor: 4.749

5.  Reversion of atrial fibrillation to sinus rhythm with digitalis therapy.

Authors:  P B JENNINGS; N MAKOUS; J B VANDER VEER
Journal:  Am J Med Sci       Date:  1958-06       Impact factor: 2.378

6.  The action of cardiac glycosides on experimental auricular flutter.

Authors:  A FARAH; T A LOOMIS
Journal:  Circulation       Date:  1950-11       Impact factor: 29.690

Review 7.  Atrial flutter and atrial fibrillation: drug therapy and recent observation.

Authors:  A L Waldo; R W Henthorn; V J Plumb
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

8.  Effects of digitalis on atrial vulnerability.

Authors:  T R Engel; A D Gonzalez
Journal:  Am J Cardiol       Date:  1978-10       Impact factor: 2.778

9.  Clinical course of acute atrial fibrillation treated with rapid digitalization.

Authors:  P Weiner; M M Bassan; J Jarchovsky; S Iusim; L Plavnick
Journal:  Am Heart J       Date:  1983-02       Impact factor: 4.749

10.  Independent and interactive effects of digoxin and quinidine on the atrial fibrillation threshold in dogs.

Authors:  R L Gold; G B Bren; R J Katz; P J Varghese; A M Ross
Journal:  J Am Coll Cardiol       Date:  1985-07       Impact factor: 24.094

View more
  1 in total

1.  The relation of quinidine-induced elevation of serum digoxin concentration to the conversion of atrial fibrillation-flutter: a pilot study.

Authors:  S Shah; H S Friedman
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.